EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report

Faramarz Jabbari-Zadeh iD, Mujtaba M Basharat iD, Benjamin Chin-Yee iD, Chai W Phua iD, Selay Lam iD, Anargyros Xenocostas iD, Eric To iD, Cyrus C Hsia iD

Case Reports in Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/carm/6274311 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Medicine, online erschienen am 15.05.2026. Verfasst von Faramarz Jabbari-Zadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Schulich School of Medicine & Dentistry, London Health Sciences Centre, Western University, London, Ontario, Canada, uwo.ca. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amegakaryocytic thrombocytopenia is a rare hematological disorder that is characterized by absent or near‐absent megakaryocytes without evidence of other hematological abnormalities. The disease can either be congenital or acquired. Given that less than a hundred cases of acquired amegakaryocytic thrombocytopenia (AAMT) have been reported in the literature, its pathophysiology and treatment remain poorly understood. Various treatments have been proposed for AAMT, including glucocorticoids and other immunosuppressive agents, such as cyclosporine, antithymocyte globulin, and rituximab. To date, there are limited data on the role of thrombopoietin receptor agonists (TPO‐RAs) for the treatment of AAMT. We present the case of a patient who initially presented with ecchymoses, purpura, and petechiae and was ultimately diagnosed with AAMT. He was treated with eltrombopag and had an increase in platelets with decreased bleeding after approximately 6 months of eltrombopag therapy. He did not experience any side effects from eltrombopag or require any platelet transfusions during follow‐up. Treatment overlapped with cyclosporine and prednisone, but these were discontinued due to adverse effects. Our case demonstrates that TPO‐RAs can be effective novel therapeutic agents and improve patient outcomes for this rare condition.

Autor:innen und Institutionen

  • Department of Medicine, Schulich School of Medicine & Dentistry, London Health Sciences Centre, Western University, London, Ontario, Canada, uwo.ca.
  • Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada, uwo.ca.
  • Department of Medicine, Division of Hematology, Schulich School of Medicine & Dentistry, London Health Sciences Centre, Western University, London, Ontario, Canada, uwo.ca.
  • Department of Pathology and Laboratory Hematology, London Health Sciences Centre, Western University, London, Ontario, Canada, lhsc.on.ca.

ORCID-Profile: Faramarz Jabbari-Zadeh, Mujtaba M Basharat, Benjamin Chin-Yee, Chai W Phua, Selay Lam, Anargyros Xenocostas, Eric To, Cyrus C Hsia

Zitieren

APA

Jabbari-Zadeh, F., Basharat, M. M., Chin-Yee, B., Phua, C. W., Lam, S., Xenocostas, A., To, E., & Hsia, C. C. (2026). Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report. Case Reports in Medicine, 2026(1). https://doi.org/10.1155/carm/6274311

Vancouver

Jabbari-Zadeh F, Basharat MM, Chin-Yee B, Phua CW, Lam S, Xenocostas A, et al. Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report. Case Reports in Medicine. 2026;2026(1). doi:10.1155/carm/6274311

BibTeX
@article{JabbariZadeh2026,
  author = {Jabbari-Zadeh, Faramarz and Basharat, Mujtaba M and Chin-Yee, Benjamin and Phua, Chai W and Lam, Selay and Xenocostas, Anargyros and To, Eric and Hsia, Cyrus C},
  title = {Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report},
  journal = {Case Reports in Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carm/6274311}
}
Kostenlos starten →